Q2 2018 13F Holders as of 6/30/2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
12.7M
-
Number of holders
-
49
-
Total 13F shares, excl. options
-
2.12M
-
Shares change
-
+213K
-
Total reported value, excl. options
-
$44M
-
Value change
-
+$4.97M
-
Number of buys
-
34
-
Number of sells
-
-13
-
Price
-
$20.75
Significant Holders of IRADIMED CORP - Common Stock (IRMD) as of Q2 2018
51 filings reported holding IRMD - IRADIMED CORP - Common Stock as of Q2 2018.
IRADIMED CORP - Common Stock (IRMD) has 49 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.12M shares
of 12.7M outstanding shares and own 16.67% of the company stock.
Largest 10 shareholders include AMERIPRISE FINANCIAL INC (289K shares), BlackRock Inc. (229K shares), VANGUARD GROUP INC (209K shares), Ranger Investment Management, L.P. (171K shares), Mondrian Investment Partners LTD (169K shares), CADENCE CAPITAL MANAGEMENT LLC (144K shares), RENAISSANCE TECHNOLOGIES LLC (117K shares), Russell Investments Group, Ltd. (88.2K shares), Menta Capital LLC (64.8K shares), and Boston Partners (62.7K shares).
This table shows the top 49 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.